Trials / Completed
CompletedNCT02009072
Comparison Between Sutureless and Glue Free Versus Sutured Limbal Conjunctival Autograft in Primary Pterygium Surgery
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 150 (actual)
- Sponsor
- Shaaban Elwan · Academic / Other
- Sex
- All
- Age
- 24 Years – 74 Years
- Healthy volunteers
- Not accepted
Summary
Pterygium is a common ocular pathology facing ophthalmologists that has varied surgical management techniques and high rate of post-operative recurrence. The investigators aim was to compare and evaluate the safety and efficacy outcomes of those two surgical procedures in management of primary pterygium.
Detailed description
Design: Prospective randomized clinical trial comparative study. Setting: Department of ophthalmology, Al-Minia University Faculty of medicine, Egypt. Methods: The study included 150 eyes of 150 patients of primary pterygium. Twenty four to 74 years of age (mean 49 ± 12 years). Simple excision under local anesthesia was performed then closure of the bare sclera by sutureless and glue free conjunctival autograft in 50 eyes of 50 patients (group 1), versus sutured free conjunctival autograft in 100 eyes of 100 patients (group 2).
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| PROCEDURE | Sutureless and glue free limbal conjunctival autograft | Simple pterygium excision under local anesthesia was performed then closure of the bare sclera by sutureless and glue free conjunctival autograft in 50 eyes of 50 patients (group 1) |
| PROCEDURE | Sutured limbal conjunctival autograft | Simple pterygium excision under local anesthesia was performed then closure of the bare sclera by sutured limbal conjunctival autograft in 100 eyes of 100 patients (group 2). |
Timeline
- Start date
- 2010-04-01
- Primary completion
- 2010-10-01
- Completion
- 2012-11-01
- First posted
- 2013-12-11
- Last updated
- 2014-01-07
Locations
1 site across 1 country: Egypt
Source: ClinicalTrials.gov record NCT02009072. Inclusion in this directory is not an endorsement.